Jane Street Group, LLC Equillium, Inc. Transaction History

Jane Street Group, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$0.73 - $3.0 $21,692 - $89,148	29,716 Added 246.81%	41,756 $96,000
Q4 2023 Feb 14, 2024	BUY	$0.48 - $0.74 $5,779 - $8,909	12,040 New	12,040 $8,000
Q2 2022 Aug 16, 2022	SELL	$1.69 - $3.26 $25,380 - $48,958	-15,018 Closed	0 $0
Q1 2022 May 17, 2022	BUY	$2.99 - $4.19 $44,903 - $62,925	15,018 New	15,018 $47,000
Q1 2021 May 18, 2021	SELL	$5.03 - $10.5 $106,786 - $222,915	-21,230 Closed	0 $0
Q4 2020 Feb 17, 2021	BUY	$3.48 - $6.58 $73,880 - $139,693	21,230 New	21,230 $114,000

11.5M

38.1K

Ticker EQ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,352,100
Market Cap $47.1M
Description
Equillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. The company's lead product candidate is itolizumab (EQ001), a clinical-stage monoclonal antibody that targets the novel immune checkpoint receptor CD6, which i...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.